View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Soomit Datta
  • Soomit Datta

PYPL US (Buy, TP: $80, +23%) PayPal - Apple Pay features update: Impl...

Apple yesterday announced the launch of a number of additional features to Apple Pay, including BNPL/instalment plans, rewards/incentives and access to third party browsers. Apple Pay is something we addressed for PayPal in our initiation, PayPal - Life in the Fast Lane, and PayPal’s personalisation efforts on Branded – as highlighted again yesterday at an investor conference by CFO Jamie Miller – remain hard for Apple to match as a pass-through wallet.

 PRESS RELEASE

Vera Therapeutics Appoints Christy J. Oliger to Board of Directors

Vera Therapeutics Appoints Christy J. Oliger to Board of Directors BRISBANE, Calif., June 11, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the appointment of Christy J. Oliger to its board of directors, effective June 7, 2024. Ms. Oliger brings over 30 years of experience in the biopharmaceutical industry, including being recognized for building highly effective teams and leading significant co...

 PRESS RELEASE

New Insight Service Accelerates Data Analytics Adoption with Microsoft...

CHANDLER, Ariz.--(BUSINESS WIRE)-- (NASDAQ:NSIT), a Microsoft Azure Expert Managed Service Provider and Featured Partner for Microsoft Fabric, has launched a fast-start service that accelerates the adoption of data analytics across the enterprise through the use of Microsoft Fabric. Companies seeking to implement generative AI and analytics often struggle to access the necessary data due to its various formats and locations within the organization. A data fabric enables access to all data without requiring relocation to a different environment. The architecture solution reduces the imple...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: June 8, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: June 7, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Vera Therapeutics to Participate in the Goldman Sachs 45th Annual Glob...

Vera Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference BRISBANE, Calif., June 07, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that the Company’s management team will participate in the Goldman Sachs 45th Annual Global Healthcare Conference, taking place June 10 – 13, 2024 at the Loews Miami Beach Hotel, Miami Beach, FL.  Presentation Details: Date: Wedn...

 PRESS RELEASE

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule ...

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BRISBANE, Calif., June 07, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on June 4, 2024, the Compensation Committee of Vera’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 31,250 shares of Class A common stock and restricted stock units (RSUs) for 14,500 shares of Class A common stock to five new employees under Vera’s 2024 Inducement Plan (the Inducement Plan). The Compensation Committee approved the awards as an ind...

Soomit Datta
  • Soomit Datta

PYPL US (Buy, TP: $80, +28%) PayPal Initiation - BUY: Life in the Fas...

Almost nine months in, new CEO Alex Chriss is looking to pivot PayPal to value (from price) and better leverage its unique two-sided (consumer/merchant) advantages it has over competitors such as Adyen, Stripe and even Apple Pay. The first evidence of this is Braintree’s more rational approach to pricing contract renewals – good for all in the market. Next we Deep dive into Fastlane, a new guest checkout; we look at how this can lift unbranded volume (first) and pricing (to follow). Other areas ...

 PRESS RELEASE

Insight to Present at Stifel 2024 Cross Sector Conference

CHANDLER, Ariz.--(BUSINESS WIRE)-- Insight Enterprises, Inc. (Nasdaq: NSIT) (the “Company”) today announced that it is scheduled to participate in the following upcoming investor conference: Stifel 2023 Cross Sector Insight Conference Tuesday, June 4, 2024, 11:30 AM ET Participants: Joyce Mullen, CEO and Glynis Bryan, CFO The Insight presentation will be broadcast live over the Internet at where you can also view other recent webcasts, downloadable slide presentations and other investor information. About Insight Insight Enterprises, Inc. is a global Fortune 500 Solutions Integrator h...

 PRESS RELEASE

Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation f...

Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin A Nephropathy (IgAN) BRISBANE, Calif., May 28, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to atacicept for the treatment of IgAN. The designation reflects the FDA’s determination that, based on an ass...

 PRESS RELEASE

Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematu...

Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association Congress 72-week data consistent with disease modification in IgAN, selected as a best-ranked abstract;Rapid and sustained improvements in hematuria over 36 weeks, with resolution in significantly greater percentage of participants than placebo; BRISBANE, Calif., May 25, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing ...

Markel Group Inc: 1 director

A director at Markel Group Inc sold 3,000 shares at 1,638.395USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...

Valens Research
  • Valens Research

Valens Equity Weekly Insights - 2024 05 21

Fidelity National Information Services (FIS) bit off more than it could chew with its WorldPay acquisition. Management has since recognized that and has taken steps to get back to its core business while focusing on growing and improving efficiency. Uniform Accounting highlights that the market is missing that FIS is already starting to execute, indicating equity upside. FIS is one of the giants in the payment processing industry. It specializes in working with the banks, and its WorldPay acqui...

 PRESS RELEASE

Insight Works with Microsoft, Qualcomm as Early Provider of Next-Gener...

CHANDLER, Ariz.--(BUSINESS WIRE)-- (NASDAQ: NSIT) is playing a key role in testing equipped to take full advantage of the new AI-featured Windows operating system update announced Monday by Microsoft. Insight will be among the first to adopt Windows-based AI PCs with dedicated neural processing units (NPU) powered by Qualcomm Snapdragon X Elite processors. The devices by Microsoft Surface, Dell, HP and Lenovo will feature the new Windows 11 always-on AI experience with a new version of Copilot+ that is contextually aware of on-device information. Insight, a Microsoft Solution partner holdi...

Insight Enterprises, Inc.: New Issuer

Our credit view of this issuer reflects its favorable profit margins relative to supply-chain peers, offset by its exposure to IT spending volatility.

Insight Enterprises, Inc.: New Issuer

Our credit view of this issuer reflects its favorable profit margins relative to supply-chain peers, offset by its exposure to IT spending volatility.

 PRESS RELEASE

Insight Enterprises, Inc. Announces Pricing of $500 Million Offering o...

CHANDLER, Ariz.--(BUSINESS WIRE)-- Insight Enterprises, Inc. (NASDAQ: NSIT) (the “Company”) announced today that it has priced $500 million aggregate principal amount of 6.625% senior notes due 2032 (the “notes”). The Company expects to use the net proceeds of the offering to repay a portion of the outstanding borrowings under its senior secured revolving credit facility due 2027 and, to the extent of any remaining net proceeds, for general corporate purposes. The sale of the notes is expected to close on May 20, 2024, subject to customary closing conditions. The notes will be senior unsecur...

Moody's Ratings assigns Ba2 CFR to Insight Enterprises and Ba3 to prop...

Moody's Ratings (Moody's) assigned a Ba2 Corporate Family Rating (CFR) and Ba2-PD Probability of Default Rating to Insight Enterprises, Inc. (Insight Enterprises). Moody's also assigned a Ba3 to the proposed senior unsecured notes and a SGL-2 Speculative Grade Liquidity (SGL) rating. Net proceeds fr...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch